The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour

Archives of Physiology and Biochemistry

Volumn 124, Issue 4, 2018, Pages 306-312

  Abildgaard, Anders ^a,b   Elfving, Betina ^a   Hokland, Marianne ^a   Wegener, Gregers ^a,c   Lund, Sten ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Blood glucose; depression; diabetes mellitus; insulin; xenobiotics

Indexed keywords

3-(INDOL-3-YL)PROPIONIC ACID; ANTIDIABETIC AGENT; INDOLE DERIVATIVE; INSULIN; PROPIONIC ACID DERIVATIVE;

ANALYSIS; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BLOOD; DEPRESSION; DIETARY SUPPLEMENT; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LEUKOCYTE COUNT; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVENTION AND CONTROL; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INDOLES; INSULIN; INSULIN RESISTANCE; LEUKOCYTE COUNT; MALE; PREDIABETIC STATE; PROPIONATES; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 85033400940     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813455.2017.1398262     Document Type: Article

References (52)

1. Abildgaard, A., et al., 2017. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology, 79, 40–48
2. An, H.M., et al., 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids in health disease, 10, 116
3. Basciano, H., Federico, L., and Adeli, K., 2005. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & metabolism), 2 (1), 5
4. Bendheim, P.E., et al., 2002. Development of indole-3-propionic acid (OXIGON) for Alzheimer’s disease. Journal of molecular neuroscience, 19 (1–2), 213–217
5. Bravo, J.A., et al., 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academic Science of the United States of America, 108 (38), 16050–16055
6. Cacho, J., et al., 2008. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague–Dawley rats. American journal of physiology. endocrinology and metabolism, 295 (5), E1269–E1276
7. Calcia, M.A., et al., 2016. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berlin), 233 (9), 1637–1650
8. Careau, V., et al., 2012. Are voluntary wheel running and open-field behavior correlated in mice? Different answers from comparative and artificial selection approaches. Behavioral genetics, 42 (5), 830–844
9. Chimerel, C., et al., 2014. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell reports, 9 (4), 1202–1208
10. Chyan, Y.J., et al., 1999. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. Journal of biological chemistry, 274 (31), 21937–21942
11. Copeland, S., et al., 2005. Acute inflammatory response to endotoxin in mice and humans. Clinical and diagnostic laboratory immunology, 12 (1), 60–67
12. Cryan, J.F., and Dinan, T.G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience, 13 (10), 701–712
13. Desbonnet, L., et al., 2010. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience, 170 (4), 1179–1188
14. Detke, M.J., Rickels, M., and Lucki, I., 1995. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin), 121 (1), 66–72
15. Frank, M.G., et al., 2007. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain, behavior, and immunity, 21 (1), 47–59
16. Grau, V., et al., 2000. Monocytes in the rat. Immunobiology, 202 (1), 94–103
17. Hogg, S., 1996. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, biochemistry, and behavior, 54 (1), 21–30
18. Hotamisligil, G.S., 2006. Inflammation and metabolic disorders. Nature, 444 (7121), 860–867
19. Hwang, I.K., et al., 2009. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. Journal of Neuroscience research, 87, 2126–2137
20. Jefferies, W.A., Green, J.R., and Williams, A.F., 1985. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. Journal of experimental medicine, 162 (1), 117–127
21. Jennis, M., et al., 2017. Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterology & motility. doi:10.1111/nmo.13178 [Accessed 7 August 2017]
22. Karbownik, M., et al., 2001. Indole-3-propionic acid, a melatonin-related molecule, protects hepatic microsomal membranes from iron-induced oxidative damage: relevance to cancer reduction. Journal of cellular biochemistry, 81 (3), 507–513
23. Karbownik, M., et al., 2005. Comparison of potential protective effects of melatonin, indole-3-propionic acid, and propylthiouracil against lipid peroxidation caused by potassium bromate in the thyroid gland. Journal of cellular biochemistry, 95 (1), 131–138
24. Kim, K.A., et al., 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS one, 7 (10), e47713
25. Knol, M.J., et al., 2006. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia, 49 (5), 837–845
26. Kuhn, B., et al., 2006. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists. Bioorganic & medicinal chemistry letters, 16 (15), 4016–4020
27. Le Chatelier, E., et al., 2013. Richness of human gut microbiome correlates with metabolic markers. Nature, 500, 541–546
28. Lee, C.T., et al., 2014. White blood cell subtypes, insulin resistance and beta-cell dysfunction in high-risk individuals–the PROMISE cohort. Clinical endocrinology, 81, 536–541
29. Ley, R.E., et al., 2006. Microbial ecology: human gut microbes associated with obesity. Nature, 444 (7122), 1022–1023
30. Liang, S., et al., 2015. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience, 310, 561–577
31. Lou, M., et al., 2015. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC endocrine disorders, 15 (1), 9
32. Luppino, F.S., et al., 2010. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of general psychiatry, 67 (3), 220–229
33. Matthews, D.R., et al., 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28 (7), 412–419
34. Mayer-Davis, E.J., et al., 1998. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA, 279, 669–674
35. Mcintyre, R.S., et al., 2009. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Current diabetes reports, 9 (1), 51–59
36. Moller, D.E., 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 414 (6865), 821–827
37. Neal, M.D., et al., 2006. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. Journal of immunology, 176 (5), 3070–3079
38. Nouwen, A., et al., 2010. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia, 53, 2480–2486
39. Porsolt, R.D., Le Pichon, M., and Jalfre, M., 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature, 266 (5604), 730–732
40. Puurunen, J., et al., 2016. A non-targeted metabolite profiling pilot study suggests that tryptophan and lipid metabolisms are linked with ADHD-like behaviours in dogs. Behavioral and brain functions, 12 (1), 27
41. Ramos, A., et al., 1997. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioural brain research, 85 (1), 57–69
42. Rothhammer, V., et al., 2016. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nature medicine, 22 (6), 586–597
43. Sanders, M.E., 2016. Probiotics and microbiota composition. BMC medicine, 14 (1), 82
44. Slattery, D.A., and Cryan, J.F., 2012. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nature protocols, 7 (6), 1009–1014
45. Speakman, J.R., and O’rahilly, S., 2012. Fat: an evolving issue. Disease models & mechanisms, 5 (5), 569–573
46. Turnbaugh, P.J., et al., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444 (7122), 1027–1031
47. Venkatesh, M., et al., 2014. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity, 41 (2), 296–310
48. Vrieze, A., et al., 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology, 143 (4), 913–916 e7
49. Walsh, R.N., and Cummins, R.A., 1976. The open-field test: a critical review. Psychological bulletin, 83 (3), 482–504
50. Wang, X., et al., 2014. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis, 234 (1), 206–213
51. Wikoff, W.R., et al., 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy Science of the United States of America, 106 (10), 3698–3703
52. Zheng, P., et al., 2016. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Molecular psychiatry, 21 (6), 786–796